1 year return (CAGR)
11.93%
Beam Therapeutics Inc Exchange (NASDAQ, USD)
BEAM
24.12
+0.13 (+0.54%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-1.38%
5 year return (CAGR)
-26.51%
10 year return (CAGR)
-
Objective Corporation Stock Analysis – State Within State
Read MoreMarketcap
2.49B
Price/Sales
15.97
Ent value
2.59B
Price/Book
2.33
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-27.94%
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 24.00 |
| Daily high | 24.93 |
| Daily low | 23.99 |
| Daily Volume | 1.46M |
| All-time high | 133.60 |
| 1y analyst estimate | 52.15 |
| Beta | 2.23 |
| EPS (TTM) | -0.82 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | 3 Mar 2026 |
Downside potential
Loading...
Downside potential data
| BEAM | S&P500 | |
| Current price drop from All-time high | -81.95% | -2.19% |
| Highest price drop | -89.12% | -56.47% |
| Date of highest drop | 8 Apr 2025 | 9 Mar 2009 |
| Avg drop from high | -60.54% | -10.68% |
| Avg time to new high | 43 days | 12 days |
| Max time to new high | 1306 days | 1805 days |
News
